glp-1 drugs for sleep apnea Efficacy of Receptor agonists in treating Obstructive apnea: A systematic review and meta-analysis of cardiometabolic and respiratory outcomes Latest Insights on GLP-1 Therapy
Description
A recent randomized and double-blind trial revealed that, for adults with poorly controlled T2DM, oral semaglutide at total doses of 25 mg and 50 mg was more effective than the 14-mg total dose in reducing HbA1c and body weight (33)
c in patients with concurrent T2DM
This food-first approach may also encourage the microbial activity and gut-brain signaling that influence appetite and digestion
In addition, the incretin hormones slow gastric emptying, thereby delaying the absorption of food (and, in particular, glucose) a further mechanism in reducing post-meal hyperglycaemia
